278 related articles for article (PubMed ID: 31844089)
1. IL-17
Lückel C; Picard F; Raifer H; Campos Carrascosa L; Guralnik A; Zhang Y; Klein M; Bittner S; Steffen F; Moos S; Marini F; Gloury R; Kurschus FC; Chao YY; Bertrams W; Sexl V; Schmeck B; Bonetti L; Grusdat M; Lohoff M; Zielinski CE; Zipp F; Kallies A; Brenner D; Berger M; Bopp T; Tackenberg B; Huber M
Nat Commun; 2019 Dec; 10(1):5722. PubMed ID: 31844089
[TBL] [Abstract][Full Text] [Related]
2. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
[TBL] [Abstract][Full Text] [Related]
4. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.
Huber M; Heink S; Pagenstecher A; Reinhard K; Ritter J; Visekruna A; Guralnik A; Bollig N; Jeltsch K; Heinemann C; Wittmann E; Buch T; Prazeres da Costa O; Brüstle A; Brenner D; Mak TW; Mittrücker HW; Tackenberg B; Kamradt T; Lohoff M
J Clin Invest; 2013 Jan; 123(1):247-60. PubMed ID: 23221338
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
Smith MD; Calabresi PA; Bhargava P
Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
Liebmann M; Korn L; Janoschka C; Albrecht S; Lauks S; Herrmann AM; Schulte-Mecklenbeck A; Schwab N; Schneider-Hohendorf T; Eveslage M; Wildemann B; Luessi F; Schmidt S; Diebold M; Bittner S; Gross CC; Kovac S; Zipp F; Derfuss T; Kuhlmann T; König S; Meuth SG; Wiendl H; Klotz L
Brain; 2021 Nov; 144(10):3126-3141. PubMed ID: 34849598
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.
Schlöder J; Berges C; Luessi F; Jonuleit H
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134847
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate-induced IL-17
Brück J; Glocova I; Geisel J; Kellerer C; Röcken M; Ghoreschi K
Eur J Immunol; 2018 Sep; 48(9):1588-1591. PubMed ID: 30007005
[TBL] [Abstract][Full Text] [Related]
10. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
[TBL] [Abstract][Full Text] [Related]
11. Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
Medina S; Villarrubia N; Sainz de la Maza S; Lifante J; Costa-Frossard L; Roldán E; Picón C; Álvarez-Cermeño JC; Villar LM
Mult Scler; 2018 Sep; 24(10):1317-1327. PubMed ID: 28653862
[TBL] [Abstract][Full Text] [Related]
12. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
Front Immunol; 2018; 9():1097. PubMed ID: 29896193
[TBL] [Abstract][Full Text] [Related]
13. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
14. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
Marastoni D; Buriani A; Pisani AI; Crescenzo F; Zuco C; Fortinguerra S; Sorrenti V; Marenda B; Romualdi C; Magliozzi R; Monaco S; Calabrese M
Front Immunol; 2019; 10():1666. PubMed ID: 31379857
[No Abstract] [Full Text] [Related]
15. Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis.
Lima ADR; Ferrari BB; Pradella F; Carvalho RM; Rivero SLS; Quintiliano RPS; Souza MA; Brunetti NS; Marques AM; Santos IP; Farias AS; Oliveira EC; Santos LMB
Front Immunol; 2024; 15():1391949. PubMed ID: 38765015
[TBL] [Abstract][Full Text] [Related]
16. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.
Wipke BT; Hoepner R; Strassburger-Krogias K; Thomas AM; Gianni D; Szak S; Brennan MS; Pistor M; Gold R; Chan A; Scannevin RH
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33468560
[TBL] [Abstract][Full Text] [Related]
17. Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.
Mansilla MJ; Navarro-Barriuso J; Presas-Rodríguez S; Teniente-Serra A; Quirant-Sánchez B; Ramo-Tello C; Martínez-Cáceres EM
CNS Neurosci Ther; 2019 Sep; 25(9):995-1005. PubMed ID: 31066225
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
[TBL] [Abstract][Full Text] [Related]
20. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
